Skip to main content
All lobbying filings

TODD STRATEGY GROUP

TODD STRATEGY GROUP filed a Q3 report for VAXART INC. on October 19, 2026, reporting $60,000 in lobbying income.

Lobbying for VAXART INC. · Clinical-stage biotechnology company.

All filings by TODD STRATEGY GROUP · Everything VAXART INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Lobbyists on this filing 2
  • DANIEL M TODD
    Previously held: Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid
  • PAUL EDATTEL
    Previously held: Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 1

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Medical/Disease Research/Clinical Labs

Vaccine policy. Pandemic preparedness. Public health.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem